Claims
- 1. A method of treating a disorder comprising implanting stem cells, progeny thereof, or combinations thereof, into a gastrointestinal organ of a subject affected with the disorder.
- 2. The method of claim 1 wherein the implanted cells repopulate neurons, muscles, or other tissues.
- 3. The method of claim 1 wherein the cells provide a source of biological material for therapeutic treatment.
- 4. The method of claim 1 wherein the stem cells are selected from the group of multipotent, pluripotent, totipotent stem cells, and combinations thereof.
- 5. The method of claim 1 wherein the cells are neural stem cells.
- 6. The method of claim 5 wherein the cells thereof are derived from embryonic neural tissue, adult neural tissue, or combinations thereof.
- 7. The method of claim 1 wherein the gastrointestinal organ comprises a solid organ.
- 8. The method of claim 7 wherein the solid gastrointestinal organ is the liver, the gall bladder, or the pancreas.
- 9. The method of claim 1 wherein the gastrointestinal organ comprises a hollow organ.
- 10. The method of claim 9 wherein the hollow gastrointestinal organ is the mouth, the esophagus, the stomach, or the bowels.
- 11. The method of claim 1 wherein implanting cells into a gastrointestinal organ of a subject comprises administering the cells locally.
- 12. The method of claim 11 wherein administering cells locally comprises injecting the cells into a wall of the gastrointestinal tract.
- 13. The method of claim 1 wherein implanting cells into a gastrointestinal tract comprises administering the cells systemically.
- 14. The method of claim 1 wherein the disorder comprises degenerative, immunologic/inflammatory, neoplastic, or idiopathic conditions of the gastrointestinal tract.
- 15. A method of treating a disorder comprising implanting stem cells, progeny thereof, or combinations thereof, into a gastrointestinal organ of a subject affected with the disorder wherein the gastrointestinal organ comprises a solid organ or a hollow organ.
- 16. A method of treating a disorder comprising implanting stem cells, progeny thereof, or combinations thereof, into a gastrointestinal organ of a subject affected with a disorder comprising degenerative, immunologic/inflammatory, neoplastic, or idiopathic conditions of the gastrointestinal tract, wherein the implanted cells repopulate neurons, muscles, or other tissues.
- 17. A method of producing enhanced levels of insulin in a subject comprising implanting stem cells and/or progeny thereof into the pancreas of the subject.
- 18. The method of claim 17 wherein the stem cells are selected from the group of multipotent, pluripotent, totipotent stem cells, and combinations thereof.
- 19. The method of claim 17 wherein the cells are neural stem cells.
- 20. The method of claim 17 wherein the cells thereof are derived from embryonic neural tissue, adult neural tissue, or combinations thereof.
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Application Serial No. 60/196,806, filed Apr. 13, 2000, and U.S. Provisional Application Serial No. 60/232,301, filed Sep. 12, 2000, which are incorporated herein by reference in its entirety.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60196806 |
Apr 2000 |
US |
|
60232301 |
Sep 2000 |
US |